Live Breaking News & Updates on About Digestive Disease

Stay updated with breaking news from About digestive disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new efficacy and safety data from the Phase 3 QUASAR Induction Study. ....

Spring House , British Columbia , United States , Craig Stoltz , Jessicar Allegretti , National Institutes Of Health , Janssen Pharmaceutical Companies Of Johnson , None Of The Janssen Pharmaceutical Companies , Companies Of Johnson , Janssen Research Development , American Society For Gastrointestinal Endoscopy , Centers For Disease , Crohn Colitis Foundation , American Gastroenterological Association , Crohn Colitis Foundation Of America , Exchange Commission , Colitis Center , Janssen Pharmaceutical Companies , Society For Surgery Of The Alimentary Tract , Digestive Disease , Annual Meeting , Medical Director , Study Outcomes , About Digestive Disease , American Association , Liver Diseases ,

Johnson & Johnson : First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis

That cause chronic inflammation of the gastrointestinal tract.6 Prolonged inflammation results in damage to the GI tract.6 The exact cause of IBD is unknown but may be the result of the immune. | May 9, 2023 ....

United States , Spring House , Jessicar Allegretti , Craig Stoltz , National Institutes Of Health , Colitis Center , Crohn Colitis Foundation Of America , American Society For Gastrointestinal Endoscopy , Exchange Commission , Society For Surgery Of The Alimentary Tract , Centers For Disease , Janssen Pharmaceutical Companies , None Of The Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , American Gastroenterological Association , Janssen Research Development , Crohn Colitis Foundation , Companies Of Johnson , Digestive Disease , Annual Meeting , Medical Director , Study Outcomes , About Digestive Disease , American Association , Liver Diseases , American Society ,